SUSAN GEORGE: Open Payments
NPI 1821056797 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,447 in 109 payments from 29 companies in 2025. Trend: 2023 $2,470 · 2024 $3,528 · 2025 $3,447
Food & beverage: $3,447
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 31 | $956 |
| Gilead Sciences, Inc. | 13 | $925 |
| ABBVIE INC. | 14 | $183 |
| GlaxoSmithKline, LLC. | 5 | $181 |
| Vanda Pharmaceuticals Inc. | 3 | $168 |
| Madrigal Pharmaceuticals | 1 | $143 |
| Eisai Inc. | 2 | $141 |
| Merck Sharp & Dohme LLC | 5 | $83 |
| Ardelyx, Inc. | 4 | $70 |
| Dexcom, Inc. | 3 | $69 |
Products named: CABENUVA, Biktarvy, APRETUDE, FANAPT, REZDIFFRA, Leqembi, RUKOBIA, AREXVY.
Industry payments across KS — which companies pay providers there.
